Most significantly, the level of Lp-PLA2 was significantly higher in the AIS group than that in the control group (147.94 ± 41.48 vs. 88.75 ± 27.76, p = 0.001). The gene discussed is PLA2G7; the disease is androgen insensitivity syndrome.